Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study

American Journal of Hypertension

Volumn 13, Issue 2, 2000, Pages 146-156

  Staessen, Jan A ^a   Kuznetsova, Tatyana ^a   Roels, Harry A ^b   Emelianov, Dmitri ^a   Fagard, Robert ^a  

^a Hypertensie Cardiovasculaire R   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Blood pressure; Cadmium; Environmental exposure; Hypertension

Indexed keywords

CADMIUM; ZINC;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXPOSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CADMIUM; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION;

EID: 0034006398     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00187-9     Document Type: Article

References (42)

1. Järup L., Berglund M., Elinder C.G., Nordberg G., Vahter M. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand J Work Environ Health. 24:(suppl 1):1998;1-51.
2. Grandjean P., Brown S.S., Reavey P., Young D.S. Biomarkers in environmental toxicology state of the art . Clin Chem. 41:1995;1902-1929.
3. Bernard A., Lauwerys R. Cadmium in human population. Experientia. 40:1984;143-152.
4. Nordberg G.F., Kjellström T., Nordberg M. Kinetics and metabolism. Friberg L., Elinder C.G., Kjellström T., Nordberg G.F. Cadmium and Health A Toxicological and Epidemiological Appraisal. Volume I. Exposure, Dose, and Metabolism . 1985;103-178 CRC Press, Boca Raton, FL.
5. Perry H.M. Jr, Erlanger M.W. Metal-induced hypertension following chronic feeding of low doses of cadmium and mercury. J Lab Clin Med. 83:1974;541-547.
6. Schroeder H.A., Vinton W.H. Jr. Hypertension induced in rats by small doses of cadmium. Am J Physiol. 202:1962;515-518.
7. Staessen J., Amery A., Bernard A., Bruaux P., Buchet J.P., Bulpitt C.J., Claeys F., De Plaen P., Ducoffre G., Fagard R., Lauwerys R.R., Lijnen P., Nick L., Saint-Remy A., Roels H., Rondia D., Sartor F., Thijs L. Blood pressure, the prevalence of cardiovascular diseases and exposure to cadmium a population study . Am J Epidemiol. 134:1991;257-267.
8. Buchet J.P., Staessen J., Roels H., Lauwerys R., Fagard R. Geographical and temporal differences in the urinary excretion of inorganic arsenic a Belgian population study . Occup Environ Med. 53:1996;320-327.
9. Staessen J.A., Fagard R., Thijs L., Amery A. A consensus view on the technique of ambulatory blood pressure monitoring. Hypertension. 26:1995;912-918.
10. Conway J., Johnston J., Coats A., Somers V., Sleight P. The use of ambulatory blood pressure monitoring to improve the accuracy and to reduce the number of subjects in clinical trials of antihypertensive agents. J Hypertens. 6:1988;111-116.
11. Lauwerys R., Amery A., Bernard A., Bruaux P., Buchet J.P., Claeys F., De Plaen P., Ducoffre G., Fagard R., Lijnen P., Nick L., Roels H., Rondia D., Saint-Remy A., Sartor F., Staessen J. Health effects of environmental exposure to cadmium objectives, design and organization of the Cadmibel study: a cross-sectional morbidity study carried out in Belgium from 1985 to 1989 . Environ Health Perspect. 87:1990;283-289.
12. Staessen J.A., Lauwerys R.R., Ide G., Roels H.A., Vyncke G., Amery A. Renal function and historical environmental cadmium pollution from zinc smelters. Lancet. 343:1994;1523-1527.
13. Staessen J.A., Lauwerys R.R., Buchet J.P., Bulpitt C.J., Rondia D., Vanrenterghem Y., Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med. 327:1992;151-156.
14. Staessen J.A., Roels H., Fagard R. Lead exposure and conventional and ambulatory blood pressure. A prospective population study. JAMA. 275:1996;1563-1570.
15. Staessen J., Bulpitt C.J., Fagard R., Joossens J.V., Lijnen P., Amery A. Salt intake and blood pressure in the general population a controlled intervention trial in two towns . J Hypertens. 6:1988;965-973.
16. Petrie J.C., O'Brien E.T., Littler W.A., de Swiet M. Recommendations on blood pressure measurement by a working party of the British Hypertension Society. Br Med J. 293:1989;611-615.
17. O'Brien E., Mee F., Atkins N., O'Malley K. Evaluation of the SpaceLabs 90202 non-invasive ambulatory recorder according to the AAMI Standard and BHS criteria. J Hum Hypertens. 5:1991;223-226.
18. Thijs L., Staessen J., Fagard R. Analysis of the diurnal blood pressure curve. High Blood Press Cardiovasc Prev. 1:1992;17-28.
19. Staessen J.A., Fagard R., Amery A. Life style as a determinant of blood pressure in the general population. Am J Hypertens. 7:1994;685-694.
20. Staessen J.A., Ginocchio G., Thijs L., Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens. 11:1997;507-514.
21. Claeys F., Ducoffre G., Sartor F., Roels H. Analytical quality control of cadmium and lead in blood and cadmium in urine results of its implementation during a five-year epidemiological study . Nordberg G.F., Herber R.F.M., Alessio L. Cadmium in the Human Environment Toxicity and Carcinogenicity . 1992;83-92 International Agency for Research on Cancer, Lyon.
22. Siegel S., Castellan N.J. Jr. The case of one sample. Two measures or paired replicates. Nonparametric Statistics for the Behavioral Sciences. 1988;73-102 McGraw-Hill, New York.
23. Kjellström T. Appendix Itai-Itai disease . Friberg L., Elinder C.G., Kjellström T., Nordberg G.F. Cadmium and Health A Toxicological and Epidemiological Appraisal. Volume II. Exposure, Dose, and Metabolism . 1985;257-290 CRC Press, Boca Raton, FL.
24. Whittemore A.S., DiCiccio Y., Provenzano G. Urinary cadmium and blood pressure results from the NHANES II survey . Environ Health Perspect. 91:1991;133-140.
25. Staessen J., Bulpitt C.J., Roels H., Bernard A., Fagard R., Joossens J.V., Lauwerys R., Lijnen P., Amery A. Urinary cadmium and lead concentration and their relationship to blood pressure in a population with low exposure. Br J Ind Med. 41:1984;241-248.
26. Staessen J., Yeoman W.B., Fletcher A.E., Markowe H.L.J., Marmot M.G., Rose G., Semmence A., Shipley M.J., Bulpitt C.J. Blood cadmium in London civil servants. J Epidemiol. 19:1990;362-366.
27. Mancia G., Bertinieri G., Grassi G., Parati G., Pomidossi G., Ferrari A., Gregorini L., Zanchetti A. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet. ii:1983;695-698.
28. Pickering T.G., James G.D., Boddie C., Harshfield G.A., Blank S., Laragh J.H. How common is white coat hypertension? JAMA. 259:1988;225-228.
29. Staessen J.A., Byttebier G., Buntinx F., Celis H., O'Brien E.T., Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. JAMA. 278:1997;1065-1072.
30. Flanagan P.R., McLellan J.S., Haist J., Cherian M.G., Chamberlain M.J., Valberg L.S. Increased dietary cadmium absorption in mice and human subjects with iron deficiency. Gastroenterology. 74:1978;841-846.
31. Elinder C.G. Cadmium uses, occurrence and intake . Friberg L., Elinder C.G., Kjellström T., Nordberg G.F. Cadmium and Health A Toxicological and Epidemiological Appraisal. Volume I. Exposure, Dose and Metabolism . 1985;23-63 CRC Press, Boca Raton, FL.
32. Cryer P.E., Haymond M.W., Santiago J.V., Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 295:1976;573-577.
33. Aronow W.S., Goldsmith J.R., Kern J.C., Cassidy J., Nelson W.H., Johnson L.L., Adams W. Effect of smoking cigarettes on cardiovascular hemodynamics. Arch Environ Health. 1974;330-332.
34. Trap-Jensen J., Carlsen J.E., Svendsen T.L., Christensen N.J. Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans. Eur J Clin Invest. 9:1979;181-183.
35. 1-inhibition. J Hypertens. 8:(suppl 5):1990;S35-S40.
36. Benowitz N.L., Sharp D.S. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation. 80:1989;1309-1312.
37. Green M.S., Jucha E., Luz Y. Blood pressure in smokers and nonsmokers epidemiologic findings . Am Heart J. 111:1986;932-940.
38. Savdie E., Grosslight G.M., Adena M.A. Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. J Chron Dis. 37:1984;617-623.
39. St George I.M., Williams S., Stanton W.R., Silva P.A. Smoking and blood pressure in 15 year olds in Dunedin, New Zealand. Br Med J. 302:1991;89-90.
40. Benowitz N.L. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 319:1988;1318-1330.
41. Cousins R.J. Absorption, transport and hepatic metabolism of copper and zinc special reference to metallothionein and ceruloplasmin . Physiol Rev. 65:1985;238-309.
42. Thijs L., Staessen J., Amery A., Bruaux P., Buchet J.P., Claeys F., De Plaen P., Ducoffre G., Lauwerys R.R., Lijnen P., Nick L., Saint-Remy A., Roels H., Rondia D., Sartor F. Determinants of serum zinc in a random population sample of four Belgian towns with different degrees of environmental exposure to cadmium. Environ Health Perspect. 98:1993;251-258.